Regulation on Precursor Acquisition
Meets the criterion.
Mexico has a binding federal framework governing the acquisition of chemical precursors. The legislation requires transaction registration, identification of participants, documentation of origin and destination, verification of counterparties, record retention, and reporting of unusual transactions.
Implementation is supported by a mandatory health permit for domestic acquisition and by the operation of the Integrated Substances System as a registration and traceability mechanism. Public evidence does not provide consolidated figures on applications, approvals, denials, alerts, inspections, violations, or diversion-prevention outcomes. This limitation affects performance assessment but does not undermine the verified existence and operation of the national regime.
Sources (4): the documents that support the traffic light
- Permisos sanitarios de estupefacientes, psicotrópicos y sustancias químicas — COFEPRIS (Document · 2024)
- Comisión Interamericana para el Control del Abuso de Drogas. (2024). Mexico: Multilateral Evaluation Mechanism (MEM), Comprehensive Evaluation (Report)
- Cámara de Diputados del H. Congreso de la Unión. (2026). Ley Federal para el Control de Precursores Químicos, Productos Químicos Esenciales y Máquinas para Elaborar Cápsulas, Tabletas y/o Comprimidos (Legislation)
- Gobierno de México. (s. f.). Permiso sanitario de importación, exportación y adquisición en plaza de estupefacientes, psicotrópicos y precursores químicos, COFEPRIS-03-023 (Regulation or programme)
Links lead to the original document or to its archived copy.